Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe EP News Bureau Aug 2, 2023 Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
